Skip to main content

and
  1. No Access

    Article

    PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California

    Approximately 5% of patients with cutaneous squamous cell carcinoma (CSCC) may develop recurrent or metastatic disease. The management of such cases is challenging and requires multi-disciplinary care. Immunot...

    Gino K. In, Poorva Vaidya, Alexandra Filkins in Journal of Cancer Research and Clinical On… (2021)